Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity

被引：0
|
作者：
Rosenstock, Julio
Coskun, Tamer
Hartman, Mark L.
Lou, Jitong
Wu, Qiwei
Du, Yu
Gurbuz, Sirel
Mather, Kieren J.
Milicevic, Zvonko
Thomas, Melissa K.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-266-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
266-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [11] beta-cell receptors for glucagon/GLP-1? Properties of exendin(9-39) in mouse islets
    Kofod, H
    Kirk, O
    Adelhorst, K
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1996, 157 (03): : 347 - 347
  • [12] Orforglipron Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes
    Rosenstock, Julio
    Robins, Deborah A.
    Duffin, Kevin L.
    Wilson, Jonathan M.
    Mather, Kieren J.
    Banerjee, Hiya
    Lin, Yanzhu
    Eyde, Sarah
    Kazda, Christof M.
    Konig, Manige
    [J]. DIABETES, 2024, 73
  • [13] Impaired beta cell adaptation to reduced insulin sensitivity and increased insulin clearance explain glucose intolerance in mice with deletion of GLP-1 and GIP receptors
    Tura, A.
    Bizzotto, R.
    Yamada, Y.
    Seino, Y.
    Omar, B. A.
    Pacini, G.
    Ahren, B.
    [J]. DIABETOLOGIA, 2016, 59 : S132 - S132
  • [14] Structure-function of the glucagon receptor family of G protein-coupled receptors: The glucagon, GIP, GLP-1, and GLP-2 receptors
    Brubaker, PL
    Drucker, DJ
    [J]. RECEPTORS & CHANNELS, 2002, 8 (3-4): : 179 - 188
  • [15] Healthcare Professionals' Perceptions of Obesity & Agonists of the Glucagon, GLP-1 and GIP Receptors
    Garvey, W. Timothy
    Mahle, Cathy
    Kushner, Robert
    [J]. OBESITY, 2023, 31 : 106 - 106
  • [16] Healthcare Professionals' Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors
    Garvey, W. Timothy
    Mahle, Cathy D.
    Kushner, Robert F.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [17] A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
    Al-Zamel, Noura
    Al-Sabah, Suleiman
    Luqmani, Yunus
    Adi, Lobna
    Chacko, Siby
    Schneider, Tom Dario
    Krasel, Cornelius
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [18] A dual GLP-1/GIP agonist may encompass the beneficial effects of both incretins on pancreatic beta cell function in the absence of beta-arrestin2
    Zaimia, N.
    Costes, S.
    Dalle, S.
    Bertrand, G.
    Ravier, M. A.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 81 - 82
  • [19] Weekly dual GIP/GLP-1 receptor agonist tirzepatide monotherapy improved markers of islet cell function and insulin sensitivity in people with type 2 diabetes (SURPASS-1)
    Lee, C. J.
    Thieu, V. T.
    Mao, H.
    Thomas, M. K.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 245 - 246
  • [20] Effects of an RYGB on β-Cell Sensitivity to GLP-1 and GIP examined
    Lichert, Frank
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (12):
12345